<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04855851</url>
  </required_header>
  <id_info>
    <org_study_id>USeville-AJRD</org_study_id>
    <nct_id>NCT04855851</nct_id>
  </id_info>
  <brief_title>Effectiveness of Pain Neuroscience Education and Strength Training in Fibromyalgia</brief_title>
  <acronym>PNE-ST-FM</acronym>
  <official_title>Effectiveness of Pain Neuroscience Education and Strength Training Program in Patients With Fibromyalgia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Manuel Rebollo Salas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Seville</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main goal of this study is to get to know if applying both, pain neuroscience education&#xD;
      (PNE) plus strength training (ST) will reduce the pain of fibromyalgia (FM). Both therapies&#xD;
      have shown evidence of improvement in fibromyalgia patients. However, there are no studies&#xD;
      evaluating their efficacy in combination.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      At present, the increase in knowledge about the neuroscience of pain has led to the&#xD;
      integration of psychological factors, such as cognitions and beliefs about pain,&#xD;
      fear-avoidance behaviors or catastrophism within the integrative perception of the concept .&#xD;
      This has led to the development of therapeutic strategies aimed at the reconceptualization of&#xD;
      pain through a treatment method called Pain Neuroscience Education (PNE), having shown&#xD;
      evidence in the treatment of pain, disability, catastrophism and physical performance.&#xD;
&#xD;
      But despite current advances in pain neuroscience, there are still pain syndromes, such as&#xD;
      fibromyalgia, that are the subject of debate and controversy. Fibromyalgia is a syndrome that&#xD;
      causes generalized musculoskeletal pain, fatigue, sleep disorders, and physical disability.&#xD;
      It is the main cause of chronic generalized musculoskeletal pain, with a prevalence of 1-5%&#xD;
      of the world population. Scientific research has provided new insight for the diagnosis of&#xD;
      fibromyalgia patients, who are characterized by a central sensitization process.&#xD;
&#xD;
      Objectives:&#xD;
&#xD;
      To assess the effectiveness of Pain Neuroscience Education and Strength Training to decrease&#xD;
      pain and disability; and increasing quality of life and functionality in patients with&#xD;
      Fibromyalgia.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2021</start_date>
  <completion_date type="Anticipated">September 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Self-report Pain Intensity</measure>
    <time_frame>at the start of the study (at baseline, 0 week), after the last treatment session (12th week), 1 month from the last session (16th week), 3 months from the last session (20th week) and 6 months from the last session (32th week).</time_frame>
    <description>Evaluated by the visual analogue scale (VAS). The total VAS score is between 0-10 cm. A higher score indicates greater pain intensity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Disability</measure>
    <time_frame>at the start of the study (at baseline, 0 week), after the last treatment session (12th week), 1 month from the last session (16th week), 3 months from the last session (20th week) and 6 months from the last session (32th week)</time_frame>
    <description>Measured by the Fibromyalgia Impact Questionnaire (FIQ). The total FIQ score is between 0-100. Thus, 0 represents the highest functional capacity and quality of life and 100 the worst state.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Quality of Life</measure>
    <time_frame>at the start of the study (at baseline, 0 week), after the last treatment session (12th week), 1 month from the last session (16th week), 3 months from the last session (20th week) and 6 months from the last session (32th week)</time_frame>
    <description>Measured by the Fibromyalgia Impact Questionnaire (FIQ). The total FIQ score is between 0-100. Thus, 0 represents the highest functional capacity and quality of life and 100 the worst state.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from Central Sensitization symptoms</measure>
    <time_frame>at the start of the study (at baseline, 0 week), after the last treatment session (12th week), 1 month from the last session (16th week), 3 months from the last session (20th week) and 6 months from the last session (32th week)</time_frame>
    <description>Measured by the Central Sensitization Inventory (CSI).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Autonomic Disfunction symptoms</measure>
    <time_frame>at the start of the study (at baseline, 0 week), after the last treatment session (12th week), 1 month from the last session (16th week), 3 months from the last session (20th week) and 6 months from the last session (32th week)</time_frame>
    <description>Measured by the Heart Rate Variability.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Nerve Conduction Velocity</measure>
    <time_frame>at the start of the study (at baseline, 0 week), after the last treatment session (12th week), 1 month from the last session (16th week), 3 months from the last session (20th week) and 6 months from the last session (32th week)</time_frame>
    <description>Measured by the Sensory Nerve Action Potential (SNAP).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Fibromyalgia</condition>
  <arm_group>
    <arm_group_label>PAIN NEUROSCIENCE EDUCATION AND STRENGTH TRAINING</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will receive 6 PAIN NEUROSCIENCE EDUCATION (PNE) sessions and 12 weeks (3 times/week) of STRENGTH TRAINING (ST)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>USUAL CARE</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The subjects of this group will receive Usual Care. In Spain, the treatment provided is mainly pharmacological, adjusted to the symptomatic profile of theses patients, and recommendation of aerobic and flexibility exercise</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PAIN NEUROSCIENCE EDUCATION AND STRENGTH TRAINING</intervention_name>
    <description>The subjects of this group will receive an amount of six sessions that will be applied within 12 weeks. Every 15 days, the subjects will come for a consultation to receive a PNE session and review of the exercise program, which will be carried out 3 times a week for 12 weeks.</description>
    <arm_group_label>PAIN NEUROSCIENCE EDUCATION AND STRENGTH TRAINING</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>USUAL CARE</intervention_name>
    <description>Aerobic exercises will consist of a standard table of low intensity stretching exercises, commonly prescribed to fibromyalgia patients. There will be three series of 30 seconds of each stretch, having a total duration of approximately 40 minutes. Each session will be held twice a week, following the recommendations of the &quot;American College of Sport Medicine&quot;. Monitoring will be performed every 15 days by a physiotherapist.</description>
    <arm_group_label>USUAL CARE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women diagnosed with fibromyalgia.&#xD;
&#xD;
          -  Duration of pain greater than one year.&#xD;
&#xD;
          -  Generalized or present paijn in more than two body regions.&#xD;
&#xD;
          -  Not having participated in pain neuroscience education program.&#xD;
&#xD;
          -  Not having participated in physical exercise programs in the last three months.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of other diseases not related to the musculoskeletal system.&#xD;
&#xD;
          -  Being under medical treatment not related to pain.&#xD;
&#xD;
          -  being under physiotherapeutic treatment related to pain.&#xD;
&#xD;
          -  Unavailability to carry out a physical exercise program.&#xD;
&#xD;
          -  Pregnant or puerperium women.&#xD;
&#xD;
          -  Inability to perform or complete the necessary tests to measure the study variables.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Álvaro-José Rodríguez-Domínguez, PT, MSc</last_name>
    <phone>+34629301910</phone>
    <email>ajrodom@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Grupo de Investigación Área de Fisioterapia CTS 305 - Universidad de Sevilla</name>
      <address>
        <city>Sevilla</city>
        <zip>41009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Álvaro-José Rodríguez-Domínguez, PT, MSc</last_name>
      <phone>+34629301910</phone>
      <email>ajrodom@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Álvaro-José Rodríguez-Domínguez, PT, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Manuel Rebollo-Salas, PT, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>José-Jesús Jiménez-Rejano, PT, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Raquel Chillón-Martínez, PT, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mercedes Álvarez-López, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Andrade A, de Azevedo Klumb Steffens R, Sieczkowska SM, Peyré Tartaruga LA, Torres Vilarino G. A systematic review of the effects of strength training in patients with fibromyalgia: clinical outcomes and design considerations. Adv Rheumatol. 2018 Oct 22;58(1):36. doi: 10.1186/s42358-018-0033-9.</citation>
    <PMID>30657077</PMID>
  </reference>
  <reference>
    <citation>Serrat M, Sanabria-Mazo JP, García-Troiteiro E, Fontcuberta A, Mateo-Canedo C, Almirall M, Feliu-Soler A, Méndez-Ulrich JL, Sanz A, Luciano JV. Efficacy of a Multicomponent Intervention for Fibromyalgia Based on Pain Neuroscience Education, Exercise Therapy, Psychological Support, and Nature Exposure (NAT-FM): Study Protocol of a Randomized Controlled Trial. Int J Environ Res Public Health. 2020 Jan 19;17(2). pii: E634. doi: 10.3390/ijerph17020634.</citation>
    <PMID>31963773</PMID>
  </reference>
  <reference>
    <citation>Nelson NL. Muscle strengthening activities and fibromyalgia: a review of pain and strength outcomes. J Bodyw Mov Ther. 2015 Apr;19(2):370-6. doi: 10.1016/j.jbmt.2014.08.007. Epub 2014 Aug 19. Review.</citation>
    <PMID>25892394</PMID>
  </reference>
  <reference>
    <citation>Barrenengoa-Cuadra MJ, Angón-Puras LÁ, Moscosio-Cuevas JI, González-Lama J, Fernández-Luco M, Gracia-Ballarín R. [Effectiveness of pain neuroscience education in patients with fibromyalgia: Structured group intervention in Primary Care]. Aten Primaria. 2021 Jan;53(1):19-26. doi: 10.1016/j.aprim.2019.10.007. Epub 2020 Feb 6. Spanish.</citation>
    <PMID>32033824</PMID>
  </reference>
  <reference>
    <citation>Louw A, Diener I, Butler DS, Puentedura EJ. The effect of neuroscience education on pain, disability, anxiety, and stress in chronic musculoskeletal pain. Arch Phys Med Rehabil. 2011 Dec;92(12):2041-56. doi: 10.1016/j.apmr.2011.07.198. Review.</citation>
    <PMID>22133255</PMID>
  </reference>
  <reference>
    <citation>Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Häuser W, Fluß E, Choy E, Kosek E, Amris K, Branco J, Dincer F, Leino-Arjas P, Longley K, McCarthy GM, Makri S, Perrot S, Sarzi-Puttini P, Taylor A, Jones GT. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017 Feb;76(2):318-328. doi: 10.1136/annrheumdis-2016-209724. Epub 2016 Jul 4. Review.</citation>
    <PMID>27377815</PMID>
  </reference>
  <reference>
    <citation>Sarzi-Puttini P, Giorgi V, Marotto D, Atzeni F. Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment. Nat Rev Rheumatol. 2020 Nov;16(11):645-660. doi: 10.1038/s41584-020-00506-w. Epub 2020 Oct 6.</citation>
    <PMID>33024295</PMID>
  </reference>
  <reference>
    <citation>Marques AP, Santo ASDE, Berssaneti AA, Matsutani LA, Yuan SLK. Prevalence of fibromyalgia: literature review update. Rev Bras Reumatol Engl Ed. 2017 Jul - Aug;57(4):356-363. doi: 10.1016/j.rbre.2017.01.005. Epub 2017 Feb 8. Review. English, Portuguese.</citation>
    <PMID>28743363</PMID>
  </reference>
  <reference>
    <citation>Cabo-Meseguer A, Cerdá-Olmedo G, Trillo-Mata JL. Fibromyalgia: Prevalence, epidemiologic profiles and economic costs. Med Clin (Barc). 2017 Nov 22;149(10):441-448. doi: 10.1016/j.medcli.2017.06.008. Epub 2017 Jul 19. Review. English, Spanish.</citation>
    <PMID>28734619</PMID>
  </reference>
  <reference>
    <citation>Yunus MB. Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arthritis Rheum. 2008 Jun;37(6):339-52. doi: 10.1016/j.semarthrit.2007.09.003. Epub 2008 Jan 14.</citation>
    <PMID>18191990</PMID>
  </reference>
  <reference>
    <citation>Nijs J, Van Houdenhove B. From acute musculoskeletal pain to chronic widespread pain and fibromyalgia: application of pain neurophysiology in manual therapy practice. Man Ther. 2009 Feb;14(1):3-12. doi: 10.1016/j.math.2008.03.001. Epub 2008 Jun 3. Review.</citation>
    <PMID>18511329</PMID>
  </reference>
  <reference>
    <citation>Cagnie B, Coppieters I, Denecker S, Six J, Danneels L, Meeus M. Central sensitization in fibromyalgia? A systematic review on structural and functional brain MRI. Semin Arthritis Rheum. 2014 Aug;44(1):68-75. doi: 10.1016/j.semarthrit.2014.01.001. Epub 2014 Jan 8. Review.</citation>
    <PMID>24508406</PMID>
  </reference>
  <reference>
    <citation>Feliu-Soler A, Borràs X, Peñarrubia-María MT, Rozadilla-Sacanell A, D'Amico F, Moss-Morris R, Howard MA, Fayed N, Soriano-Mas C, Puebla-Guedea M, Serrano-Blanco A, Pérez-Aranda A, Tuccillo R, Luciano JV. Cost-utility and biological underpinnings of Mindfulness-Based Stress Reduction (MBSR) versus a psychoeducational programme (FibroQoL) for fibromyalgia: a 12-month randomised controlled trial (EUDAIMON study). BMC Complement Altern Med. 2016 Feb 27;16:81. doi: 10.1186/s12906-016-1068-2.</citation>
    <PMID>26921267</PMID>
  </reference>
  <reference>
    <citation>Assumpção A, Matsutani LA, Yuan SL, Santo AS, Sauer J, Mango P, Marques AP. Muscle stretching exercises and resistance training in fibromyalgia: which is better? A three-arm randomized controlled trial. Eur J Phys Rehabil Med. 2018 Oct;54(5):663-670. doi: 10.23736/S1973-9087.17.04876-6. Epub 2017 Nov 29.</citation>
    <PMID>29185675</PMID>
  </reference>
  <reference>
    <citation>American College of Sports Medicine Position Stand. The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exerc. 1998 Jun;30(6):975-91. Review.</citation>
    <PMID>9624661</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>April 16, 2021</study_first_submitted>
  <study_first_submitted_qc>April 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 22, 2021</study_first_posted>
  <last_update_submitted>September 28, 2021</last_update_submitted>
  <last_update_submitted_qc>September 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Seville</investigator_affiliation>
    <investigator_full_name>Manuel Rebollo Salas</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <keyword>Fibromyalgia</keyword>
  <keyword>Education</keyword>
  <keyword>Strength training</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

